199 related articles for article (PubMed ID: 25845909)
1. Universality of Oxime K203 for Reactivation of Nerve Agent-Inhibited AChE.
Kuca K; Hrabinova M; Jun D; Musilek K; Penhaker M; Krejcar O; Soukup O
Med Chem; 2015; 11(7):683-6. PubMed ID: 25845909
[TBL] [Abstract][Full Text] [Related]
2. A comparison of the ability of a new bispyridinium oxime--1-(4-hydroxyiminomethylpyridinium)-4-(4-carbamoylpyridinium)butane dibromide and currently used oximes to reactivate nerve agent-inhibited rat brain acetylcholinesterase by in vitro methods.
Kuca K; Kassa J
J Enzyme Inhib Med Chem; 2003 Dec; 18(6):529-35. PubMed ID: 15008517
[TBL] [Abstract][Full Text] [Related]
3. Oxime K027: novel low-toxic candidate for the universal reactivator of nerve agent- and pesticide-inhibited acetylcholinesterase.
Kuca K; Musilek K; Jun D; Pohanka M; Ghosh KK; Hrabinova M
J Enzyme Inhib Med Chem; 2010 Aug; 25(4):509-12. PubMed ID: 20192902
[TBL] [Abstract][Full Text] [Related]
4. A comparison of the efficacy of a bispyridinium oxime--1,4-bis-(2-hydroxyiminomethylpyridinium) butane dibromide and currently used oximes to reactivate sarin, tabun or cyclosarin-inhibited acetylcholinesterase by in vitro methods.
Kuca K; Cabal J; Kassa J
Pharmazie; 2004 Oct; 59(10):795-8. PubMed ID: 15544060
[TBL] [Abstract][Full Text] [Related]
5. A comparison of the potency of the oxime HLö-7 and currently used oximes (HI-6, pralidoxime, obidoxime) to reactivate nerve agent-inhibited rat brain acetylcholinesterase by in vitro methods.
Kuca K; Cabal J; Kassa J; Jun D; Hrabinová M
Acta Medica (Hradec Kralove); 2005; 48(2):81-6. PubMed ID: 16259317
[TBL] [Abstract][Full Text] [Related]
6. In vitro and in vivo evaluation of pyridinium oximes: mode of interaction with acetylcholinesterase, effect on tabun- and soman-poisoned mice and their cytotoxicity.
Calić M; Vrdoljak AL; Radić B; Jelić D; Jun D; Kuca K; Kovarik Z
Toxicology; 2006 Feb; 219(1-3):85-96. PubMed ID: 16332406
[TBL] [Abstract][Full Text] [Related]
7. Reactivation of nerve agent-inhibited human acetylcholinesterase by obidoxime, HI-6 and obidoxime+HI-6: Kinetic in vitro study with simulated nerve agent toxicokinetics and oxime pharmacokinetics.
Worek F; Koller M; Thiermann H; Wille T
Toxicology; 2016 Mar; 350-352():25-30. PubMed ID: 27153754
[TBL] [Abstract][Full Text] [Related]
8. Pyridinium Oximes with Ortho-Positioned Chlorine Moiety Exhibit Improved Physicochemical Properties and Efficient Reactivation of Human Acetylcholinesterase Inhibited by Several Nerve Agents.
Zorbaz T; Malinak D; Maraković N; Maček Hrvat N; Zandona A; Novotny M; Skarka A; Andrys R; Benkova M; Soukup O; Katalinić M; Kuca K; Kovarik Z; Musilek K
J Med Chem; 2018 Dec; 61(23):10753-10766. PubMed ID: 30383374
[TBL] [Abstract][Full Text] [Related]
9. An evaluation of therapeutic and reactivating effects of newly developed oximes (K156, K203) and commonly used oximes (obidoxime, trimedoxime, HI-6) in tabun-poisoned rats and mice.
Kassa J; Karasova J; Musilek K; Kuca K
Toxicology; 2008 Jan; 243(3):311-6. PubMed ID: 18054821
[TBL] [Abstract][Full Text] [Related]
10. A common mechanism for resistance to oxime reactivation of acetylcholinesterase inhibited by organophosphorus compounds.
Maxwell DM; Brecht KM; Sweeney RE
Chem Biol Interact; 2013 Mar; 203(1):72-6. PubMed ID: 22982773
[TBL] [Abstract][Full Text] [Related]
11. Reactivation of organophosphate-inhibited acetylcholinesterase by quaternary pyridinium aldoximes.
Kuca K; Patocka J; Cabal J; Jun D
Neurotox Res; 2004; 6(7-8):565-70. PubMed ID: 15639788
[TBL] [Abstract][Full Text] [Related]
12. Potency of new structurally different oximes to reactivate cyclosarin-inhibited human brain acetylcholinesterases.
Kuca K; Cabal J; Jun D; Bajgar J; Hrabinova M
J Enzyme Inhib Med Chem; 2006 Dec; 21(6):663-6. PubMed ID: 17252938
[TBL] [Abstract][Full Text] [Related]
13. Reactivation of sarin-inhibited pig brain acetylcholinesterase using oxime antidotes.
Kuca K; Jun D
J Med Toxicol; 2006 Dec; 2(4):141-6. PubMed ID: 18072133
[TBL] [Abstract][Full Text] [Related]
14. A comparison of reactivating and therapeutic efficacy of the oxime K203 and its fluorinated analog (KR-22836) with currently available oximes (obidoxime, trimedoxime, HI-6) against tabun in rats and mice.
Kassa J; Karasova JZ; Caisberger F; Musilek K; Kuca K; Jung YS
J Enzyme Inhib Med Chem; 2010 Aug; 25(4):480-4. PubMed ID: 20233085
[TBL] [Abstract][Full Text] [Related]
15. In vitro reactivation potency of acetylcholinesterase reactivators--K074 and K075--to reactivate tabun-inhibited human brain cholinesterases.
Kuca K; Cabal J; Jun D; Musilek K
Neurotox Res; 2007 Feb; 11(2):101-6. PubMed ID: 17449453
[TBL] [Abstract][Full Text] [Related]
16. Oxime-mediated in vitro reactivation kinetic analysis of organophosphates-inhibited human and electric eel acetylcholinesterase.
Sahu AK; Sharma R; Gupta B; Musilek K; Kuca K; Acharya J; Ghosh KK
Toxicol Mech Methods; 2016 Jun; 26(5):319-26. PubMed ID: 27101948
[TBL] [Abstract][Full Text] [Related]
17. Currently used cholinesterase reactivators against nerve agent intoxication: comparison of their effectivity in vitro.
Kuca K; Jun D; Bajgar J
Drug Chem Toxicol; 2007; 30(1):31-40. PubMed ID: 17364862
[TBL] [Abstract][Full Text] [Related]
18. A comparison of reactivating and therapeutic efficacy of bispyridinium acetylcholinesterase reactivator KR-22934 with the oxime K203 and commonly used oximes (obidoxime, trimedoxime, HI-6) in tabun-poisoned rats and mice.
Kassa J; Karasova JZ; Pavlikova R; Musilek K; Kuca K; Bajgar J; Jung YS
Toxicol Mech Methods; 2011 Mar; 21(3):241-5. PubMed ID: 21142778
[TBL] [Abstract][Full Text] [Related]
19. New quaternary pyridine aldoximes as casual antidotes against nerve agents intoxications.
Kuca K; Bartosová L; Jun D; Patocka J; Cabal J; Kassa J; Kunesová G
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2005 Jun; 149(1):75-82. PubMed ID: 16170392
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and in vitro evaluation of novel non-oximes for the reactivation of nerve agent inhibited human acetylcholinesterase.
de Koning MC; Horn G; Worek F; van Grol M
Chem Biol Interact; 2020 Aug; 326():109139. PubMed ID: 32454005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
